Netflix Stock Price Soars After Earnings Report Record New Memberships
Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the
If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today
They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many
Wisr AI Systems Inc. Accelerates Global Business Development at Web Summit Vancouver, InfoSec Europe, and VivaTech Paris
Newsfile
1 hours ago
Vancouver, British Columbia--(Newsfile Corp. - June 22, 2025) - Wisr AI Systems Inc. (CSE: WISR) ("Wisr AI" or the "Company"), a leading provider of AI-driven cyber and third-party risk intelligence, is pleased to announce the successful execution of
WNP Launches All-in-One Hyaluronic Acid Skincare Set, Pioneering a "3-Step Scientific Skincare Method"
Newsfile
2 hours ago
Culver City, California--(Newsfile Corp. - June 22, 2025) - Skincare brand WNP officially launched the "All-in-One Hyaluronic Acid Skincare Set" on its website, introducing its original "Three-Step Scientific Skincare Method." The set integrates five
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
GlobeNewswire Inc.
8 hours ago
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano MedPromising tumor accumulation and attractive biodistribution shown in
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
GlobeNewswire Inc.
Jun 21, 2025 10:00 PM GMT
Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy Data support development of next-generation APJ agonists for obesity and
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting
GlobeNewswire Inc.
Jun 21, 2025 12:00 PM GMT
SEATTLE, June 21, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, announced two presentati
Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial
GlobeNewswire Inc.
Jun 21, 2025 12:00 PM GMT
[212Pb]VMT-α-NET Phase 1/2a study is advancing into Cohort 3 with a fixed administered dose that is up to 20% higher (6 mCi) than the dose administered to patients in Cohort 2Dosimetry sub-study analysis presented at the Society of Nuclear Medicine &
The China Fund, Inc. Announces Board Approval of Plan of Liquidation
GlobeNewswire Inc.
Jun 21, 2025 1:48 AM GMT
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- The China Fund, Inc. (NYSE: CHN) (the “Fund”) announced today that its Board of Directors (the “Board”) has approved a plan of liquidation and dissolution (the “Plan”) for the Fund. The Plan will be submitt
Enzon and Viskase Enter into Merger Agreement
GlobeNewswire Inc.
Jun 21, 2025 12:16 AM GMT
Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD, N.J. and LOMBARD, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQX: ENZN) (“Enzon” or the “Company”) and V
East Africa Metals Appoints New Director
Newsfile
Jun 21, 2025 12:00 AM GMT
Vancouver, British Columbia--(Newsfile Corp. - June 20, 2025) - East Africa Metals Inc. (TSXV: EAM) ("East Africa Metals" or the "Company") is pleased to announce the appointment of Mr. Gang Chen (aka Asa Chen) as a Director of the Company. Mr. Chen
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
GlobeNewswire Inc.
Jun 20, 2025 11:30 PM GMT
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming la
